FEMA549852
ApoC3 Recombinant Rabbit Monoclonal Antibody (8H12), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | FEMA549852-Each-of-1 | In Stock | ₹ 37,202.00 |
FEMA549852 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 37,202.00
GST (18%): ₹ 6,696.36
Total Price: ₹ 43,898.36
Antigen
ApoC3
Classification
Recombinant Monoclonal
Concentration
0.25 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide, pH 7.4
Gene Accession No.
P02656
Gene Symbols
APOC3
Immunogen
A synthesized peptide derived from human APOC3
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Form
Liquid
Applications
ELISA, Immunohistochemistry (Paraffin)
Clone
8H12
Conjugate
Unconjugated
Gene
APOC3
Gene Alias
Apoc3, APOCIII, Apo-CIII, apoC-III, Apolipoprotein, Apolipoprotein C3, apolipoprotein C-3, apolipoprotein C-III, HALP2, MGC150353
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
345
Content And Storage
-20°C or -80°C if preferred
Isotype
IgG
Related Products
Description
- Apolipoprotein C-III, also known as apo-CIII, is a protein that in humans is encoded by the APOC3 gene
- Apo-CIII is a component of very low density lipoprotein (VLDL)
- APOC3 inhibits lipoprotein lipase and hepatic lipase; it is thought to delay catabolism of triglyceride-rich particles
- The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes
- The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed
- An increase in apoC-III levels induces the development of hypertriglyceridemia.